News
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
Stellantis, the maker of Jeep and Ram vehicles, says its preliminary financial figures show an estimated 2.3 billion euros ...
Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in important areas within the pharma industry. Investors could see the two ...
A Turkish study finds Pfizer’s COVID-19 vaccine may cause temporary changes in corneal thickness and cell count, raising ...
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Guggenheim ...
SALT LAKE CITY, Utah, July 21, 2025 (SEND2PRESS NEWSWIRE) — (MMI), the original pioneer in mortgage market intelligence, ...
Explore more
Pittsburgh, USA-based Viatris, which was formed in 2020 through the merger of Mylan and Pfizer's, saw its shares fall 4.2% to ...
Pfizer recently recalibrated its evaluation score, a nod to shifting trends in the market and its own financial pulse. The ...
BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come ...
Gold Spot US Dollar, Intel Corporation, Microsoft Corporation, Cisco Systems Inc. Read 's Market Analysis on Investing.com UK.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results